论文部分内容阅读
多发性骨髓瘤(multiple myeloma,MM)是浆细胞异常增生的恶性肿瘤,以老年病人居多,以往多以化疗为主,耐药或复发是导致治疗失败的主要原因,传统的化疗方案有:MP(美法仑+泼尼松)、M2(卡莫司丁+美法仑+泼尼松+长春新碱+环磷酰胺)和VAD(长春新碱+多柔比星+地塞米松)等。患者的中位?
Multiple myeloma (MM) is a malignant tumor of plasma cell dysplasia. Most of the patients are elderly patients. Mostly chemotherapy was the main cause. The drug resistance or recurrence was the main reason for the failure of treatment. The traditional chemotherapy regimens include: MP (Melphalan + prednisone), M2 (carmustine + melphalan + prednisone + vincristine + cyclophosphamide) and VAD (vincristine + doxorubicin + dexamethasone), etc. . Patient’s median?